. Author manuscript; available in PMC: 2017 Dec 1.

Published in final edited form as: Endocr Relat Cancer. 2016 Sep 27;23(12):899–908. doi: 10.1530/ERC-16-0231

Table 1.

Findings on ophthalmology consultation

Patient	Visual Acuity^*	Optic Disc Fibrosis (bilateral)	Posterior Pole (Macular) Changes	Peripheral Retinal Changes	Other
1	RE: 20/16 LE: 20/16	Present	Vascular tortuosity with dilated veins Few arteriolar narrowing and subtle retinal pigmentary changes	Bilateral peripheral scattered retinal pigment epithelial (RPE) changes
2	RE: 20/32 LE: 20/25	Present	Absent	Absent	Bilateral cataract (posterior subcapsular)
3^◊	RE: 20/25 LE: 20/25	Present	Absent	Bilateral peripheral retinal neovascularization present; LE: single hemangioblastoma-like lesion similar to VHL in the inferior temporal retina	Myelinated nerve fiber layer in LE
4	RE: 20/20 LE: 20/20	Present	Absent	Bilateral temporal vasculature anomalies similar to familial exudative vitreoretinopathy / retinopathy of prematurity like appearance with U-turning blood vessels
5^◊	RE: 20/25 LE: 20/32	Present	Bilateral macular edema^** with retinal hard exudate	Absent	Bilateral enlarged blind spot
6^◊	RE: 20/20 LE: 20/63	Present	Absent	Absent	LE with optic nerve head drusen and amblyopia
7^◊	RE: 20/250 LE: 20/20	Present	Macular edema^*** with hard exudate RE only	Absent

Visual Acuity: measured on a LogMAR Visual Acuity Chart (Early Treatment Diabetic Retinopathy Study visual acuity chart) at 4 meters, best corrected

^**

Intravitreal injection of Ranibizumab was administered

^***

Intravitreal injection of Bevacizumab was administered

^◊